Biocon Biologics Integrates Viatris Business As It Introduces Adalimumab
Completes ‘First Wave’ Of Viatris Integration And Launches US Hulio Rival To Humira
• By David Wallace
Multiple developments have been seen for Biocon’s biosimilars business • Source: Shutterstock 
